Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Lung Neoplasms and LCT[original query] |
---|
Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer. Oncology letters 2012 Feb 3 (2): 415-420. Lu Hong-Yang, Su Dan, Pan Xiao-Dan, Jiang Hong, Ma Sheng-L |
Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer. Journal of cancer research and clinical oncology 2014 Dec 140 (12): 2097-105. Deng Li-Li, Deng Hong-Bin, Lu Chang-Lian, Guo Yang, Wang Di, Yan Chun-Hua, Lv Xing, Shao Yu-X |
Germline mutations causing familial lung cancer. Journal of human genetics 2015 Jul . Tomoshige Koichi, Matsumoto Keitaro, Tsuchiya Tomoshi, Oikawa Masahiro, Miyazaki Takuro, Yamasaki Naoya, Mishima Hiroyuki, Kinoshita Akira, Kubo Toru, Fukushima Kiyoyasu, Yoshiura Koh-Ichiro, Nagayasu Takes |
Association of EGFR and KRAS mutations with expression of p-AKT, DR5 and DcR1 in non-small cell lung cancer. Neoplasma 2017 Jan 64 (2): . Zhao X D, Deng H B, Lu C L, Bao Y X, Lu X, Deng L |
Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial. International journal of radiation oncology, biology, physics 2019 11 106 (2): 349-357. Tang Chad, Lee Won-Chul, Reuben Alexandre, Chang Lianpeng, Tran Hai, Little Latasha, Gumbs Curtis, Wargo Jennifer, Futreal Andrew, Liao Zhongxing, Xia Xuefeng, Yi Xin, Swisher Steven G, Heymach John V, Gomez Daniel, Zhang Jianj |
High concordance of EGFR mutation status between sputum and corresponding tissue specimens of late-stage lung cancers using amplification refractory mutation system-PCR. International journal of clinical and experimental pathology 2020 1 11 (5): 2683-2690. Su Fei, Fu Yiyun, Wu Qian, Zheng Ke, Tang Yuan, Su Xueying, Wang Ye, Jiang Li |
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Cancers 2023 4 15 (7): . Tsai Ming-Ju, Hung Jen-Yu, Ma Juei-Yang, Tsai Yu-Chen, Wu Kuan-Li, Lee Mei-Hsuan, Kuo Chia-Yu, Chuang Cheng-Hao, Lee Tai-Huang, Lee Yen-Lung, Huang Chun-Ming, Shen Mei-Chiou, Yang Chih-Jen, Chong Inn-W |
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO precision oncology 2023 1 7 e2200540. De Brian, Farooqi Ahsan S, Mitchell Kyle G, Ludmir Ethan B, Lewis Jeff, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Lee J Jack, Swisher Stephen G, Gibbons Don L, Zhang Jianjun, Le Xiuning, Elamin Yasir Y, Gomez Daniel R, Ning Matthew S, Lin Steven H, Liao Zhongxing, Chang Joe Y, Vaporciyan Ara A, Heymach John V, Antonoff Mara B, Gandhi Saumil |
- Page last reviewed:Feb 1, 2024
- Content source: